ArticleTargeted oncology2021
Correction to: Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.
Yeonghak Bang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it